1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Advanced organoid models for targeting Kras-driven lung adenocarcinoma in drug discovery and combination therapy
(
- Contribution to journal › Article
- 2024
-
Mark
Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells
(
- Contribution to journal › Article
-
Mark
Enhancing cell death in B-cell malignancies through targeted inhibition of Bcl-3
(
- Contribution to journal › Article
- 2023
-
Mark
PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia
(
- Contribution to journal › Article
- 2022
-
Mark
Engineering human mini-bones for the standardized modeling of healthy hematopoiesis, leukemia, and solid tumor metastasis
(
- Contribution to journal › Article
- 2021
-
Mark
Novel Cyclophilin Inhibitor Decreases Cell Proliferation and Tumor Growth in Models of Hepatocellular Carcinoma
(
- Contribution to journal › Article
-
Mark
Integrin α10-Antibodies Reduce Glioblastoma Tumor Growth and Cell Migration
(
- Contribution to journal › Article
- 2020
-
Mark
Discovery of epi-enprioline as a novel drug for the treatment of vincristine resistant neuroblastoma
(
- Contribution to journal › Article
-
Mark
Gene expression signature of acquired chemoresistance in neuroblastoma cells
(
- Contribution to journal › Article
-
Mark
Tumour suppressor 15-hydroxyprostaglandin dehydrogenase induces differentiation in colon cancer via GLI1 inhibition
(
- Contribution to journal › Article